Matches in Wikidata for { <http://www.wikidata.org/entity/Q79750183> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q79750183 description "artikull shkencor i botuar më 01 shkurt 2007" @default.
- Q79750183 description "artículu científicu espublizáu en febreru de 2007" @default.
- Q79750183 description "scientific article published on 01 February 2007" @default.
- Q79750183 description "wetenschappelijk artikel" @default.
- Q79750183 description "наукова стаття, опублікована в лютому 2007" @default.
- Q79750183 name "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 name "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 name "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 type Item @default.
- Q79750183 label "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 label "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 label "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 prefLabel "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 prefLabel "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 prefLabel "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 P1433 Q79750183-E4EFDC34-BA64-4881-9B5C-2FAE3EDCBC0C @default.
- Q79750183 P1476 Q79750183-F67CDDA4-3518-440B-8AFC-88F6FF0427B1 @default.
- Q79750183 P2093 Q79750183-0BA8D061-B324-47E4-9FAB-3B714A081FAE @default.
- Q79750183 P2093 Q79750183-322F005C-4975-487D-BE5B-5B6C97545464 @default.
- Q79750183 P2093 Q79750183-85CDE458-9B01-4B14-8635-65FAE7770D5D @default.
- Q79750183 P2093 Q79750183-942D0121-E2C6-40C4-9CB9-96E3EF4008C6 @default.
- Q79750183 P2093 Q79750183-B9C73980-8BC4-4B19-9B48-F8B117A63A70 @default.
- Q79750183 P2093 Q79750183-CDE97B79-1071-4CC0-853D-458F28EC5FC4 @default.
- Q79750183 P304 Q79750183-F0A6DEB6-69A0-4FEC-B350-875A2B036EED @default.
- Q79750183 P31 Q79750183-77B6A797-D0AF-4202-B0D5-1FBBB38EFC2D @default.
- Q79750183 P356 Q79750183-D4EC7E62-FE4A-4F69-98F6-88D8A7995444 @default.
- Q79750183 P433 Q79750183-F03E62E2-8E23-4CD6-A3E1-EEB924BE5BC0 @default.
- Q79750183 P478 Q79750183-57E6E05B-6B93-459C-A05F-BA724FE8F3DF @default.
- Q79750183 P577 Q79750183-006825DE-610F-44A8-BFA3-399D3D83D16C @default.
- Q79750183 P698 Q79750183-ED5C3C39-5CE7-403A-BD7A-AC3B8A0DB15D @default.
- Q79750183 P921 Q79750183-5E0717B0-702F-42C4-B2B0-FBC7B2B17025 @default.
- Q79750183 P356 1078-0432.CCR-06-1910 @default.
- Q79750183 P698 17289896 @default.
- Q79750183 P1433 Q332253 @default.
- Q79750183 P1476 "Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy" @default.
- Q79750183 P2093 "Amarnath Sharma" @default.
- Q79750183 P2093 "Barbara A Duncan" @default.
- Q79750183 P2093 "Donghua Yin" @default.
- Q79750183 P2093 "Franzanne Vreeland" @default.
- Q79750183 P2093 "Larry J Schaaf" @default.
- Q79750183 P2093 "Robert Millham" @default.
- Q79750183 P304 "1000-1009" @default.
- Q79750183 P31 Q13442814 @default.
- Q79750183 P356 "10.1158/1078-0432.CCR-06-1910" @default.
- Q79750183 P433 "3" @default.
- Q79750183 P478 "13" @default.
- Q79750183 P577 "2007-02-01T00:00:00Z" @default.
- Q79750183 P698 "17289896" @default.
- Q79750183 P921 Q725307 @default.